BioMarin Pharmaceuticals Shares Are Trading Lower After Truist Securities Lowered Its Price Target on the Stock From $140 to $118.
BioMarin Pharmaceuticals Shares Are Trading Lower After Truist Securities Lowered Its Price Target on the Stock From $140 to $118.
BioMarin Pharmaceuticals股票下跌，Truist Securities將其股票目標價從$140降至$118。
BioMarin Pharmaceuticals Shares Are Trading Lower After Truist Securities Lowered Its Price Target on the Stock From $140 to $118.
BioMarin Pharmaceuticals股票下跌，Truist Securities將其股票目標價從$140降至$118。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。